Literature DB >> 16500340

Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery.

Luigi Fedele1, Stefano Bianchi, Giovanni Zanconato, Nicola Berlanda, Ricciarda Raffaelli, Eleonora Fontana.   

Abstract

OBJECTIVE: To compare the laparoscopic excision of primary versus recurrent ovarian endometriomas.
DESIGN: Descriptive study.
SETTING: Tertiary referral center for the treatment of endometriosis. PATIENT(S): Between 1993 and 2002, 359 consecutive patients: 305 primary surgeries (group A) and 54 reoperations for a recurrent endometrioma in the same ovary of the primary cyst (group B). INTERVENTION(S): Laparoscopic stripping of the cyst wall. Follow-up evaluations every 6 months, including clinical and ultrasonographic evaluations and a questionnaire for pain symptoms (mean follow-up time, +/- standard deviation: 35.4 +/- 27.6 months). MAIN OUTCOME MEASURE(S): Recurrence of pain symptoms, sonographic recurrence of endometriomas, need for a new medical or surgical treatment, and reproductive outcome. RESULT(S): In groups A and B, respectively, the 5-year cumulative rates were not statistically significantly different: pain recurrence 20.5% versus 17.4%; ultrasonographic recurrence 18.9% versus 15.1%; retreatment requirement 19.4% versus 17.3%; and pregnancy 40.8% versus 32.4%. Although the difference was not statistically significant, compared with patients of group A, the women of group B underwent assisted reproduction techniques more frequently (50% vs. 32.2%) and had more irregular menstrual cycles associated with follicle-stimulating hormone levels > or = 14 IU/mL in the early follicular phase (5.5% vs. 1.3%). CONCLUSION(S): After laparoscopic excision of recurrent ovarian endometriomas, the recurrence of pain and the reproductive outcome are comparable with those found after primary surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16500340     DOI: 10.1016/j.fertnstert.2005.08.028

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.

Authors:  Seung-Hye Choi; Sung Eun Kim; Hyun Hye Lim; Dong-Yun Lee; DooSeok Choi
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

Review 2.  Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature.

Authors:  Ilker Selçuk; Gürkan Bozdağ
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-06-01

3.  Medical management of recurrent endometrioma with long-term norethindrone acetate.

Authors:  Ozgul Muneyyirci-Delale; Jenny Anopa; Cassandra Charles; Deepali Mathur; Rudolph Parris; Jed B Cutler; Ghadir Salame; Ovadia Abulafia
Journal:  Int J Womens Health       Date:  2012-03-30

4.  Effect of second-line surgery on in vitro fertilization outcome in infertile women with ovarian endometrioma recurrence after primary conservative surgery for moderate to severe endometriosis.

Authors:  Hana Park; Chung-Hoon Kim; Eun-Young Kim; Jei-Won Moon; Sung-Hoon Kim; Hee-Dong Chae; Byung-Moon Kang
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

5.  Treatment of ovarian endometriomas using plasma energy in endometriosis surgery: effect on pelvic pain, return to work, pregnancy and cyst recurrence.

Authors:  E K Lockyer; Amf Schreurs; McI Lier; Jjml Dekker; I Melgers; V Mijatovic
Journal:  Facts Views Vis Obgyn       Date:  2019-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.